Table 1: Demographic and clinical presentation with COVID-19 patients.
Variables |
Total |
538 |
Deceased |
92 |
Survivors |
446 |
p-value |
|
n |
% |
n |
% |
n |
% |
|
Gender |
|
|
|
|
|
|
0.5674 |
Male |
270 |
50.2 |
49 |
53.3 |
221 |
49.6 |
|
Female |
268 |
49.8 |
43 |
46.7 |
225 |
50.4 |
|
Ethnicity |
|
|
|
|
|
|
|
Black |
83 |
15.4 |
7 |
7.6 |
76 |
17 |
0.0254 |
Caucasian |
283 |
52.6 |
65 |
70.7 |
218 |
48.9 |
0.0001 |
Hispanic |
163 |
30.3 |
17 |
18.5 |
146 |
32.7 |
0.0061 |
Age, years (Mean ± SD) |
65.56 ± 19.63 |
|
79.05±13.05 |
|
62.77 ± 19.62 |
|
<0.00001 |
BMI |
|
|
|
|
|
|
|
Underweight |
40 |
7.4 |
12 |
13 |
28 |
6.3 |
0.0461 |
Normal |
133 |
24.7 |
22 |
23.9 |
121 |
27.1 |
0.6046 |
Overweight |
151 |
28.1 |
29 |
31.5 |
139 |
31.2 |
1 |
Obese |
214 |
39.8 |
29 |
31.5 |
202 |
45.3 |
0.0154 |
Living |
|
|
|
|
|
|
|
Home |
361 |
67.1 |
36 |
39.1 |
325 |
72.9 |
|
Long term care |
177 |
32.9 |
56 |
60.9 |
121 |
27.1 |
|
Symptoms |
|
|
|
|
|
|
|
Chest pain |
45 |
8.4 |
2 |
2.2 |
43 |
9.6 |
0.0206 |
Dyspnea |
285 |
53 |
50 |
54.3 |
235 |
52.7 |
0.819 |
Fever/Chills |
333 |
61.9 |
58 |
63 |
275 |
61.7 |
0.9062 |
Arrhythmia |
5 |
0.9 |
1 |
1.1 |
4 |
0.9 |
1 |
Syncope/Dizziness |
8 |
1.5 |
2 |
2.2 |
6 |
1.3 |
0.6326 |
Ear pain/Headache |
16 |
3 |
2 |
2.2 |
14 |
3.1 |
1 |
Cough |
279 |
51.9 |
36 |
39.1 |
243 |
54.5 |
0.0083 |
Altered mental state |
49 |
9.1 |
15 |
16.3 |
34 |
7.6 |
0.0152 |
Loss of smell/taste |
12 |
2.2 |
1 |
1.1 |
11 |
2.5 |
0.7009 |
Weakness/Fatigue |
131 |
24.3 |
24 |
26.1 |
107 |
24 |
0.6896 |
Diarrhea/GI Symptoms |
107 |
19.9 |
13 |
14.1 |
94 |
21.1 |
0.1517 |
NONE |
3 |
0.6 |
2 |
2.2 |
1 |
0.2 |
0.0772 |
Previous Cardiac History |
|
|
|
|
|
|
|
Ischemic Event |
60 |
11.2 |
10 |
10.9 |
50 |
11.2 |
1 |
Arrhythmia |
84 |
15.6 |
24 |
26.1 |
60 |
13.5 |
0.0042 |
Structural disease / Heart failure |
41 |
7.6 |
11 |
12 |
30 |
6.7 |
0.1273 |
Peripheral vascular disease |
21 |
3.9 |
8 |
8.7 |
13 |
2.9 |
0.0161 |
PCI/TAVR/Mitraclip |
48 |
8.9 |
11 |
12 |
37 |
8.3 |
0.3131 |
NONE |
394 |
73.2 |
57 |
62 |
337 |
75.6 |
0.0095 |
Past Medical History |
|
|
|
|
|
|
|
Hypertension |
314 |
58.4 |
314 |
58.4 |
248 |
55.6 |
0.0051 |
Obstructive sleep apnea |
54 |
10 |
54 |
10 |
46 |
10.3 |
0.8487 |
Diabetes |
173 |
32.2 |
173 |
32.2 |
139 |
31.2 |
0.2686 |
Hyperlipidemia |
209 |
38.8 |
209 |
38.8 |
160 |
35.9 |
0.0022 |
Smoker/COPD |
111 |
20.6 |
111 |
20.6 |
75 |
16.8 |
< 0.00001 |
CVA/dementia |
131 |
24.3 |
131 |
24.3 |
96 |
21.5 |
0.0013 |
NONE |
107 |
19.9 |
107 |
19.9 |
103 |
23.1 |
< 0.00001 |
LOS, days (Mean ± SD) |
12.84 ± 12.61 |
|
13.52 ±11.57 |
|
12.70 ± 12.82 |
|
0.569461 |
In-Hospital Treatment |
|
|
|
|
|
|
|
Antibiotic |
281 |
52.2 |
60 |
65.2 |
221 |
49.6 |
0.0081 |
Plaquinil |
128 |
23.8 |
23 |
25 |
105 |
23.5 |
0.7884 |
Azythromycin |
210 |
39 |
40 |
43.5 |
170 |
38.1 |
0.3495 |
Plasma |
83 |
15.4 |
16 |
17.4 |
67 |
15 |
0.5307 |
Steroid |
58 |
10.8 |
16 |
17.4 |
42 |
9.4 |
0.0401 |
Tocilizumab |
17 |
3.2 |
3 |
3.3 |
14 |
3.1 |
1 |
Remdesivir |
92 |
17.1 |
19 |
20.7 |
73 |
16.4 |
0.361 |
Home Medications |
|
|
|
|
|
|
|
Nitrates |
28 |
5.2 |
5 |
5.4 |
23 |
5.2 |
0.802 |
Anticoagulation |
44 |
8.2 |
10 |
10.9 |
34 |
7.6 |
0.2986 |
Antiarrhythmic |
19 |
3.5 |
6 |
6.5 |
13 |
2.9 |
0.1139 |
Diuretic |
95 |
17.7 |
19 |
20.7 |
76 |
17 |
0.4525 |
Antiplatelet |
154 |
28.6 |
36 |
39.1 |
118 |
26.5 |
0.0164 |
Beta Blocker |
121 |
22.5 |
29 |
31.5 |
92 |
20.6 |
0.028 |
CA Blocker |
135 |
25.1 |
30 |
32.6 |
105 |
23.5 |
0.0853 |
Statin/zetia |
174 |
32.3 |
37 |
40.2 |
137 |
30.7 |
0.0867 |
ARB |
49 |
9.1 |
12 |
13 |
37 |
8.3 |
0.1634 |
ACE |
85 |
15.8 |
12 |
13 |
73 |
16.4 |
0.5302 |
GFR |
|
|
|
|
|
|
< 0.00001 |
Abnormal |
131 |
24.3 |
47 |
51.1 |
84 |
18.8 |
|
Clot Disorder |
|
|
|
|
|
|
|
Yes |
27 |
5 |
14 |
15.2 |
13 |
2.9 |
|
Respiratory Distress |
|
|
|
|
|
|
|
Ventilator |
110 |
20.4 |
45 |
48.9 |
65 |
14.6 |
< 0.00001 |
|